Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pfenex Inc. (PFNX)

5.44 0.09 (1.68%)

07-18 15:59

Open:

5.36

Pre. Close:

5.35

High:

5.6995

Low:

5.22

Volume:

285,587

Market Cap:

171M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.623 - 5.651

5.651 - 5.679

Low:

5.109 - 5.136

5.136 - 5.163

Close:

5.306 - 5.349

5.349 - 5.394

Technical analysis  (as of: 2018-07-18 3:38:14 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 6.48     One year: 6.88

Support:

Support1: 5.00    Support2: 4.16

Resistance:

Resistance1: 5.55    Resistance2: 5.89

Pivot:

5.44

Moving Averages:

MA(5): 5.44     MA(20): 5.41

MA(100): 5.53     MA(250): 4.14

MACD:

MACD(12,26): -0.06     Signal(12,26,9): -0.07

%K %D:

%K(14,3): 37.08     %D(3): 41.70

RSI:

RSI(14): 47.81

52-Week:

High: 8.419  Low: 2.07  Change(%): 18.1

Average Vol(K):

3-Month: 24873  10-Days 18864

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PFNX has closed above bottom band by 47.8%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to PFNX's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-07-02T12:59:00-04:00
FDA withdraws draft guidance related to biosimilar development

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

23.58

Shares Float (M)

22.81

% Held by Insiders

3.30

% Held by Institutions

68.70

Shares Short (K)

158

Shares Short Prior Month (K)

Stock Financials

EPS

-1.130

EPS Est. Current Year

-2.090

EPS Est. Next Year

-2.480

EPS Est. Next Quarter

-0.580

Forward EPS

-1.271

Book Value (p.s.)

2.890

PEG Ratio

-0.09

Profit Margin

-53.81

Operating Margin

-90.65

Return on Assets (ttm)

-33.6

Return on Equity (ttm)

-44.9

Qtrly Rev. Growth

32.9

Gross Profit (p.s.)

0.228

Sales Per Share

EBITDA (p.s.)

-0.870

Qtrly Earnings Growth

Operating Cash Flow (M)

-20.84

Levered Free Cash Flow (M)

-9.86

atoplab.com

Valuation

P/E

-4.80

P/E Growth Ratio

0.01

P/BV

1.88

P/S

135069840.00

P/CF

-6.13

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.